HSPA9 and colorectal cancer: Although we did not observe a higher level of soluble mortalin in the blood of OC patients compared to the control group, extracellular soluble blood mortalin was documented in colorectal cancer, and data showed a significantly higher level of mortalin in these patients compared to control [17,32].